This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yale University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations in Radiolabeled Pharmaceuticals by Zhengxin Cai
Introduction
Zhengxin Cai is an accomplished inventor based in Cheshire, CT (US). He has made significant contributions to the field of radiolabeled pharmaceuticals, particularly in the development of compounds that can be utilized in medical imaging.
Latest Patents
Zhengxin Cai holds a patent for "Radiolabeled pharmaceuticals and methods of making and using same." This invention includes compounds that bind to the synaptic vesicle protein SV2A, which can serve as radiotracers for positron emission tomography (PET). The patent outlines methods for imaging the brain, measuring synaptic density, and diagnosing neurological diseases such as Alzheimer's disease, as well as psychiatric disorders like depression and metabolic disorders such as diabetes.
Career Highlights
Cai is affiliated with Yale University, where he continues to advance research in the field of pharmaceuticals. His work has the potential to significantly impact the diagnosis and treatment of various neurological and metabolic conditions.
Collaborations
Zhengxin Cai collaborates with notable colleagues, including Yiyun Huang and Richard E Carson, who contribute to his research endeavors.
Conclusion
Zhengxin Cai's innovative work in radiolabeled pharmaceuticals exemplifies the intersection of science and technology in improving medical diagnostics. His contributions are paving the way for advancements in the understanding and treatment of complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile